$11.160
-0.470 (-4.21%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による NTLA の予測・予想
Alphio's NTLA stock price prediction model matches the current Intellia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.17 (-0.34%). The 1-week path is $11.24 (+0.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Intellia Therapeutics Inc 株は買うべき？
Intellia Therapeutics is not a good buy right now due to significant financial losses and analyst concerns. The current price is $11.42, which is above Barclays' price target of $8, indicating a potential downside of 30%. Additionally, the RSI is at 36.2, suggesting the stock is oversold but lacks momentum for a recovery. The company is facing regulatory challenges and insider selling has increased by 2235.78%, raising red flags about future performance.
NTLA の株価は Thursday に $11.16 で引け、その前に下落 -4.21%
Intellia Therapeutics Inc (NTLA) last closed at $11.21, gaining +0.45%. These facts feed the 1-day and 1-week NTLA price prediction above.
アナリストのコンセンサス
Intellia Therapeutics Inc（NTLA）：買い 4、中立 2、売り 0。見通し：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
予想の要因
Intellia Therapeutics Inc（NTLA）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが NTLA に最も近い銘柄を、類似度順に表示します。
NTLA の季節性分析
Historically the probability of a positive October return for NTLA is 63.49%. October offers the highest probability of a positive month at 63.49%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。